Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,404,682
-
Share change
-
-272,000
-
Total reported value
-
$26,504,027
-
Put/Call ratio
-
42%
-
Price per share
-
$0.62
-
Number of holders
-
55
-
Value change
-
-$677,883
-
Number of buys
-
23
-
Number of sells
-
24
Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q4 2019
As of 31 Dec 2019,
AVEO PHARMACEUTICALS INC - COM (AVEO) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,404,682 shares.
The largest 10 holders included
NEA Management Company, LLC, VANGUARD GROUP INC, BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, X-Square Capital, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WINTON GROUP Ltd, and Evercore Wealth Management, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.